Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Head and Neck Neoplasms × Immunotherapy × Clear all

Status

Completed 3 Withdrawn 1 Unknown 1 Recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 14 Esophageal Neoplasms 7 Colorectal Neoplasms 6 Melanoma 5 Neoplasm Metastasis 4 Lung Neoplasms 4 Esophageal Squamous Cell Carcinoma 4 Small Cell Lung Carcinoma 3 Pancreatic Neoplasms 3 Uterine Cervical Neoplasms 2 Stomach Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Neoplasms 2 Nasopharyngeal Carcinoma 2 Carcinoma, Hepatocellular 2 Uveal Melanoma 1 Unresectable Biliary Tract Cancer 1 Triple Negative Breast Neoplasms 1 Thymus Neoplasms 1 Thymoma 1 Thymic epithelial tumor 1 Small Cell Lung Cancer Extensive Stage 1 Sarcopenia 1 Recurrence 1 Prostatic Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pathologic Complete Response 1 Neuroblastoma 1 Nasopharyngeal Neoplasms 1 Muscle-Invasive Bladder Carcinoma 1

Interventions

pembrolizumab 23 Cisplatin 14 Carboplatin 13 Radiotherapy 12 Blood Specimen Collection 10 Paclitaxel 9 Cetuximab 8 Fluorouracil 7 Docetaxel 7 Drug Therapy 5 toripalimab 4 atezolizumab 4 Radiation 4 tislelizumab 3 Surgical Procedures, Operative 3 Chemoradiotherapy 3 Biopsy 3 cemiplimab 2 avelumab 2 Tocopherols 2 Tiragolumab 2 Tablets 2 Surveys and Questionnaires 2 Standard of Care 2 Riluzole 2 Radiotherapy, Intensity-Modulated 2 Radiosurgery 2 Pravastatin 2 Pentoxifylline 2 Nivolumab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05328024 2023-09-22

IPRICE

Institut de cancérologie Strasbourg Europe

Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡